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CASE REPORT
T cell-lymphoma in the eyelid 
of a 9-year-old English Setter
Lauge Hjorth Mikkelsen1,2 , Frederik Holm1,2, Erik Clasen‑Linde1, Pernille Engraff3 and Steffen Heegaard1,2*
Abstract 
Background: Eyelid tumours are frequently found in dogs, most of these being benign. In case of an ulcerating 
eyelid tumour, malignancy must be considered. We report a unique case of a low‑grade peripheral T‑cell lymphoma 
in the eyelid of a 9‑year‑old English Setter.
Case presentation: A 9‑year‑old Setter presented with a 6‑month history of an eyelid ulcer. A malignant eyelid 
neoplasm was suspected, and the lesion was surgically excised. No other treatment was applied, and 19 months after 
excision the dog was still well. Histopathology revealed a diffuse lymphocytic infiltrate in the eyelid skin. Ulceration of 
the epithelium was seen, and the underlying tumour was composed of round and poorly demarcated pleomorphic 
tumour cells. The cytoplasm was pale and the nuclei heterogeneous. Numerous mitoses were present. The tumour 
cells stained strongly for CD3. The final diagnosis was a peripheral T‑cell lymphoma not otherwise specified (NOS).
Conclusions: This is the first described case of a solitary T‑cell lymphoma NOS in the haired eyelid skin in a dog. Lym‑
phoma should be considered in case of a persistent eyelid ulcer and a biopsy should be performed. T‑cell lymphoma 
is generally an aggressive disease; however, indolent cases are well known, and as this case shows, complete exci‑
sion of a solitary T‑cell lymphoma can be curable. Canine cutaneous epitheliotropic T‑cell lymphoma is an important 
differential diagnosis, which must be recognized as the prognosis is very poor and systemic treatment is mandatory. 
The sub‑classification of canine lymphoma is not complete, and further studies are needed to identify lymphoma 
subgroups and provide treatment guidelines.
Keywords: Canine, Dog, Eyelid, Lymphoma, Neoplasm, T‑cell
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Lymphoma is the most frequent haematologic malig-
nancy among dogs, and the annual incidence rate is 
13–114/100,000 [1]. Canine lymphoma may be divided 
into Hodgkin’s-like and non-Hodgkin’s-like lymphoma, 
the latter being the most frequent [2]. Furthermore, non-
Hodgkin’s-like lymphoma may be subdivided according 
to the origin of the neoplastic cells [2]. Non-Hodgkin’s-
like lymphomas with commitment to the T-cell-lineage 
represent 20% of all dog lymphomas, while the rest are of 
B-cell origin [3]. Clinically, lymphadenopathy is the most 
frequent presentation of lymphoma in dogs, however, 
extranodal lymphoma may also present with a rapidly 
growing mass due to accumulation of tumour cells in 
extranodal tissue [1, 2]. Additionally, in case of systemic 
disease, symptoms such as fever and weight loss can be 
present [1, 2].
Histopathologically, most lymphomas are character-
ized by a diffuse monoclonal lymphocytic infiltrate, 
however, follicular types also occur [2]. The tumour cells 
are further characterized based on the growth pattern, 
nuclear size, nuclear morphology, mitotic index, and 
immunophaenotype [2].
B- and T-cell lymphomas may be distinguished by 
immunohistochemistry. In humans, multiple immuno-
histochemical markers are used to separate lymphoma 
subtypes; however, many of these markers do not 
function when applied to canine tissue because most 
standard antibodies are developed for use in human 
pathology. In general, tumour cells of T-cell origin 
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demonstrate positivity for cluster of differentiation 
(CD)3, CD4, and CD8, while tumour cells of B-cell ori-
gin are positive when staining for CD19, CD20, CD79α, 
and PAX-5 [4]. In our experience, the most reliable 
immunohistochemical stainings for determining the 
lineage in dog lymphomas are PAX-5 and CD3.
Periocular and intraocular lymphomas are rare in 
dogs [4–15]. Previously, a T-cell lymphoma in the pal-
pebral conjunctiva of a dog has been reported [9], and 
to the best of our knowledge, this present case is the 
first case of a canine solitary cutaneous eyelid T-cell 
lymphoma.
Case presentation
A 9-year-old male English Setter presented with a 
6-month history of ulceration of the left upper eyelid as 
the only clinical finding (Fig.  1a). On examination, the 
lesion was round, elevated, and well circumscribed. A 
malignant eyelid tumour was suspected, and the lesion 
was excised for histopathological examination. A fine-
needle aspirate was obtained from a popliteal lymph 
node from the left side. The popliteal lymph node was 
chosen, as the owner did not want any expensive diag-
nostic procedures and the popliteal lymph node was the 
easiest accessible. The dog was doing well and presented 
without fever, clinical signs of anaemia, or weight loss. 
Fig. 1 a A 9‑year‑old male English Setter presented with a 6‑month history of an eyelid ulcer on top of a tumour measuring 10 × 14 mm. The 
lesion is round and surrounds a central area of normal eyelid epithelium with hair. b In overview, a diffuse infiltrate of lymphoid tumour cells is 
seen within the epidermis and dermis (#). A large ulceration of the epithelium is seen (arrow). The tumour cells fill the rete ridges (*) and invasion of 
the epithelium is seen in some areas. Invasion of the adnexal epithelium does not occur (haematoxylin and eosin (HE); bar: 100 µm). c The tumour 
cells have pale cytoplasm and prominent nucleoli. Numerous mitotic figures are seen (arrow). (HE; bar: 30 µm). d The tumour cells stain positive in 
anti‑CD3 staining, indicating that the tumour cells are of T‑cell origin (bar: 50 µm)
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A routine blood profile was unremarkable except for a 
haematocrit (packed cell volume, PCV) of 37%, which 
is borderline low. The blood test also showed a serum 
calcium: 2.43  mmol/L (ref 1.98–3.0  mmol/L), serum 
albumin: 31  g/L (ref 23–40  g/L), serum alkaline phos-
phatase: 53 U/L (ref 23–213 U/L), and serum creatinine: 
91  µmol/L (ref 44–159  µmol/L). Serum sodium, potas-
sium, chloride, and glucose were also within normal lim-
its. C-reactive protein (CRP) was < 10 mg/L, which is also 
normal. The owner did not want additional examinations 
or treatments other than excision of the tumour and for 
this reason, a thoracic radiograph, abdominal ultrasound, 
and a full haematological profile were not performed. 
No systemic treatment was initiated, and 2 months after 
surgery an unremarkable full haematological profile was 
obtained. 19 months after the diagnosis the dog was still 
alive and doing well with no signs of relapse.
The specimen was fixed in 10% neutral buffered for-
malin immediately after surgical excision, processed and 
embedded in paraffin. Sections (4  µm) were prepared 
and stained with haematoxylin and eosin according to 
standard protocols. Furthermore, sections were routinely 
stained with periodic acid-Schiff (PAS), Gram stain, and 
Gomori’s methenamine silver stain (GMS) to detect 
microorganisms. Giemsa staining was performed to visu-
alize the blood derived cells in the specimen.
Immunohistochemical stainings were performed on 
a Ventana Benchmark Ultra Platform (Ventana Medical 
Systems, Tucson, AZ, USA) according to manufacturer’s 
instructions. The following antibodies were used: CD3 
[clone 2GV6, code 790-4341, rabbit anti-human, ready-
to-use (RTU), Roche (Hvidovre, Denmark)], PAX-5 
[clone SP34, code 790-4420, rabbit anti-human, RTU, 
Roche (Hvidovre, Denmark)], vimentin [clone V9, code 
790-2917, mouse anti-human, RTU, Roche (Hvidovre, 
Denmark)], and Ki-67 (clone MIB-1, code M724001, 
mouse anti-human, 1:100, Dako). Positive and negative 
controls were performed according to the manufacturers’ 
instructions.
Results
Microscopically, an ulceration of the eyelid epithelium 
was seen. A diffuse lymphocytic infiltrate was observed 
within the epithelium and in the underlying dermis 
(Fig. 1b). In some areas of the dermis, the adnexal struc-
tures were surrounded by tumour cells, however, sev-
eral unaffected hair follicles and sebaceous glands were 
also observed. No invasion of the adnexal structures 
was seen. The excision margins were free from tumour 
cells. The tumour cells were round, pleomorphic and 
poorly demarcated. The tumour cells varied in size being 
approximately 14 µm in diameter and with abundant 
cytoplasm and large nuclei (Fig.  1c). The nucleoli were 
prominent and numerous mitotic figures were present. 
No tingible body macrophages were seen in the speci-
men. The tumour cells stained light blue with Giemsa 
stain, in contrast to normal lymphocytes which were 
more hyperchromatic. Scattered mast cells were seen 
within the tumour infiltrate, and numerous eosinophils 
were observed in the area under the ulceration. Numer-
ous Gram-positive cocci were seen in the outer part of 
the ulceration.
Immunohistochemistry demonstrated membranous 
and cytoplasmic positivity for CD3 in the tumour cells 
(Fig. 1d). No reaction was seen for the pan-B-cell marker 
PAX-5. Staining with Ki-67/MIB1 was positive in approx-
imately 30% of the tumour cells, indicating a rather high 
mitotic index. No tumour cells were found in the fine-
needle aspiration of the popliteal lymph node. The sam-
ple was considered diagnostic and a few normal scattered 
lymphocytes were seen in the specimen. Overall, these 
findings were consistent with a malignant solitary extran-
odal T-cell-lymphoma not otherwise specified (NOS) [1, 
3].
Discussion and conclusions
This case describes the first case of a solitary T-cell 
lymphoma in the hairy skin of the eyelid in a dog pre-
senting with a cutaneous ulceration in the eyelid. Previ-
ously, a case of a conjunctival T-cell lymphoma has been 
reported [9]. The conjunctiva is a mucosal membrane 
which harbours a part of the innate immune system 
known as mucosa associated lymphoid tissue (MALT). 
For this reason, the immunology and biology of conjunc-
tival lymphomas is different from eyelid skin lymphoma. 
Although very rare, lymphoma should be considered in 
case of a persistent treatment refractory eyelid ulcer, and 
a biopsy should always be performed. Other, more fre-
quently occurring differential diagnoses such as immune 
mediated blepharitis, chalazion, hordeolum, insect bites, 
infections, trauma, histiocytoma, mast cell tumours, or 
benign tumours such as sebaceous adenoma should be 
ruled out.
In most cases of canine lymphoma, histopathology and 
relatively simple immunophaenotyping is sufficient for 
obtaining the correct diagnosis [1, 3]. In the present case, 
the lymphocytic tumour cells were round and varied in 
size. Immunohistochemistry demonstrated tumour cells 
of T-cell origin. Overall, these findings are suggestible 
of a peripheral T-cell lymphoma NOS, according to the 
WHO classification of canine lymphomas [1, 3]. This type 
of lymphoma represents approximately 16% of all canine 
lymphomas, however, it has never been reported in the 
eyelid [1]. The presence of bacteria within the specimen 
was interpreted as a secondary infection.
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Diagnostic imaging is not recommended for staging 
purposes on a routine basis [1], and in our case it was 
not performed due to the owners’ wish. However, diag-
nostic imaging may be considered on an individual basis 
[1]. In cases with clinically suspected systemic disease, a 
blood test and/or diagnostic imaging can be performed 
to carry out a rough staging of the lymphoma according 
to the WHO stages for canine multicentric lymphoma 
[1]. For a full staging, a bone marrow biopsy should also 
be obtained. Staging may, however, not be necessary in 
all cases of a solitary lymphoma and in the present case 
it was not performed. If staging is performed, the stage 
is not necessarily a predictor of better survival [1, 13]. 
In general, however, stage I-II disease has a favourable 
prognosis, whereas stage V lymphoma usually has a poor 
prognosis if extensive bone marrow involvement is pre-
sent [16].
Clinically, no lymph nodes were involved in the present 
case, and the blood tests were normal. Serum calcium 
and albumin levels may be elevated in case of a dissemi-
nated lymphoma, and in some studies, low albumin con-
centration has been associated with a poor prognosis 
[17]. In the present case, both serum calcium and albu-
min levels were normal. Additionally, in the present case 
we examined a popliteal lymph node due to the owners 
wish. If a clinically enlarged lymph node is found, this 
lymph node should be excised and histopathologically 
examined. In cases where no clinically enlarged lymph 
node is present, a regional lymph node should be pre-
ferred to evaluate systemic involvement.
Overall, the present case is most likely a stage Ia dis-
ease, which corresponds to a lymphoma restricted to 
a single node or lymphoid tissue in a single organ with 
absence of systemic signs. No detailed haematology, 
thoracic radiographs, or abdominal ultrasound was per-
formed prior to surgery, and this makes our staging ques-
tionable. However, because the dog is doing well with no 
signs of progression 19  months after excision with free 
margins, a low-grade lymphoma seems plausible.
An important differential diagnosis of a T-cell lym-
phoma in the haired skin of a dog is the so-called canine 
cutaneous epitheliotropic T-cell lymphoma (CETL) [16]. 
This diagnosis was considered in the present case mainly 
due to the epitheliotropic growth of the lesion and the 
ulceration of the overlying epidermis. On the other hand, 
only few adnexal structures were surrounded by tumour 
cells, and invasion of tumour cells into the adnexal struc-
tures was not observed. Furthermore, dogs with CETL 
often have multiple lesions and systemic symptoms, 
which was not the case in the present study [18].
In general, lymphoma remains one of the most 
chemotherapy-responsive cancers in dogs [1, 19]. 
Unfortunately, peripheral T-cell lymphoma NOS is in 
most cases an unpredictable and aggressive haema-
tologic cancer with a poor prognosis, and the mean 
survival time is approximately 6  months [1]. The poor 
prognosis is possibly due to the aggressive nature of 
the disease, histologically demonstrated by a high pro-
liferation index and a high degree of cellular pleomor-
phism. The recommended treatment is high-intensity 
CHOP (cyclophosphamide, hydroxydaunorubicin, 
oncovin [vincristine], and prednisone)-based proto-
cols combined with various rescue protocols (such as 
mechlorethamine/procarbazine-based) [1, 3, 19]. Some 
authors suggest that l-asparaginase-MOPP (mustargen, 
oncovin, procarbazine, prednisone) may be superior to 
standard CHOP-protocols in canine T-cell lymphomas 
[1]. Other studies suggest using protocols based on an 
alkylating agent, lomustine, in the treatment of canine 
T-cell lymphomas [20]. However, indolent cases of low-
stage solitary peripheral T-cell lymphoma in dogs may 
not require systemic treatment after successful excision 
of the tumour [19]. In this light, it seems that the inclu-
sion of these low-grade cases in the aggressive group of 
peripheral T-cell lymphoma NOS is not adequate, and 
some dogs will receive aggressive chemotherapy, which 
is not needed and an expensive solution. In humans, 
lymphoma may be sub-classified according to several 
specific genetic abnormalities; however, in animals, the 
information on molecular biology is still very limited 
[1]. Nonetheless, it seems that canine lymphomas carry 
less genomic instabilities compared to human lympho-
mas [1]. This is an interesting point, as other mecha-
nisms than genomic instabilities are possibly involved 
in canine lymphoma pathogenesis when compared to 
human lymphoma, and thus canine lymphoma should 
possibly be sub-classified according to other features 
than lymphomas of humans.
This is the first reported case of a cutaneous T-cell-
lymphoma in the eyelid of a dog, a so-called peripheral 
T-cell lymphoma NOS with an indolent course. The 
existing classification systems of canine T-cell lympho-
mas may not be sufficient and there may exist multiple 
sub-classifications of T-cell lymphoma in dogs. Stud-
ies aiming to sub-classify canine lymphoma based on 
detailed immunophaenotyping and molecular biology 
have not been made. It would be of interest to perform 
larger multicentre studies to divide canine T-cell lym-
phomas into specific subcategories with differing prog-
noses and sensitivities to various treatment regimens.
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